sábado, 18 de abril de 2020

Disaster Lit® Database Daily Updates | COVID-19

Disaster Lit® Database Daily Updates

Disaster Information and Emergency Response



04/16/2020 12:00 AM EDT

Source: Centers for Disease Control and Prevention, Center for Preparedness and Response (CDC CPR). Published: 4/16/2020. This one-hour, four-minute Clinician Outreach and Communication Activity (COCA) call provides an overview of the importance of mortality data, discusses the National Center for Health Statistics (NCHS) publication and the guidance it provides to clinicians who may need to certify a death involving COVID-19, and presents a summary of COVID-19 surveillance through the National Vital Statistics System (NVSS). (Video or Multimedia)
04/15/2020 12:00 AM EDT

Source: U.S. Food and Drug Administration (FDA). Published: 4/15/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the COVID-19 ELISA IgG Antibody Test, which received an Emergency Use Authorization from the Food and Drug Administration on April 15, 2020. The COVID-19 ELISA IgG Antibody Test is authorized for use on serum or plasma specimens from individuals suspected of prior infection with the virus that causes coronavirus disease 2019 (COVID-19) by their healthcare provider. (PDF)
04/15/2020 12:00 AM EDT

Source: National Institutes of Health (NIH). Published: 4/15/2020. This hour-long presentation details how the National Institute of Allergy and Infectious Diseases (NIAID) has tapped existing coronavirus expertise and other assets during the COVID-19 pandemic to stand up research programs spanning basic virology and immunology through to countermeasure development (diagnostics, therapeutics, and vaccines). As the outbreak has expanded, so too has the NIAID research program and the scope of the problems it seeks to solve. (Video or Multimedia)
04/15/2020 12:00 AM EDT

Source: Cochrane Library. Published: 4/15/2020. This report summarizes a study to evaluate which type of full-body personal protective equipment (PPE) and which method of donning or doffing PPE have the least risk of contamination or infection for healthcare workers, and which training methods increase compliance with PPE protocols. (Text)
04/15/2020 12:00 AM EDT

Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 4/15/2020. These operational considerations are intended to be used by healthcare facilities and public health authorities in non-U.S. healthcare settings, particularly focusing on low- and middle-income countries, assisting with the management of healthcare workers exposed to a person with confirmed or suspected COVID-19. (Text)
04/15/2020 12:00 AM EDT

Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 4/15/2020. Given the high risk of spread once COVID-19 enters a long-term care facility, facilities must act immediately to protect residents, families, and staff from serious illness, complications, and death. This web page provides steps to take in five key categories. (Text)
04/15/2020 12:00 AM EDT

Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 4/15/2020. Assisted living facility (ALF) owners and administrators are urged to implement these recommendations to protect their residents and staff during the COVID-19 pandemic. (Text)
04/15/2020 12:00 AM EDT

Source: American Public Health Association (APHA). Published: 4/15/2020. The fourth one-hour COVID-19 Conversations webinar gives an overview of crisis standards of care during a pandemic, challenges for adapting such standards to rapidly evolving clinical care guidelines, practical considerations for state health departments and hospital systems, and ethical considerations to be aware of while enacting crisis standards of care. (Video or Multimedia)
04/14/2020 12:00 AM EDT

Source: U.S. Food and Drug Administration (FDA). Published: 4/14/2020. This three-page fact sheet informs healthcare personnel of the significant known and potential risks and benefits of the emergency use of decontaminated compatible N95 respirators. Compatible N95 respirators are those that do not contain cellulose-based or paper materials, natural rubber, or latex. These compatible N95 respirators have been decontaminated using the Stryker STERIZONE VP4 N95 Respirator Decontamination Cycle in the STERIZONE VP4 Sterilizer, which received an Emergency Use Authorization from the Food and Drug Administration on April 14, 2020. (PDF)
04/14/2020 12:00 AM EDT

Source: U.S. Food and Drug Administration (FDA). Published: 4/14/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the SARS-CoV-2 Fluorescent PCR Kit, which received an Emergency Use Authorization from the Food and Drug Administration on April 14, 2020. The SARS-CoV-2 Fluorescent PCR Kit is authorized for use on using respiratory specimens collected from individuals suspected of COVID-19 by their healthcare providers. (PDF)
04/14/2020 12:00 AM EDT

Source: Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services] (HHS ASPR). Published: 4/14/2020. This seven-page document from TRACIE (Technical Resources, Assistance Center, and Information Exchange) lists key COVID-19 guidance and resources for hospital administrators, hospital emergency planners, and infection control practitioners in the following topical areas: hospital surge, crisis standards of care, staffing surge and resilience, workforce protection, regulatory relief, equipment supply surge, and telemedicine. Each section contains links to federal and non-federal guidance to help hospitals prepare for and respond to a COVID-19 outbreak. (PDF)
04/14/2020 12:00 AM EDT

Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 4/14/2020. This web page provides information about a new laboratory test developed by the Centers for Disease Control and Prevention (CDC) to assist with efforts to determine how much of the U.S. population has been exposed to SARS-CoV-2, the virus that causes COVID-19. (Text)
04/14/2020 12:00 AM EDT

Source: Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services] (HHS ASPR). Published: 4/14/2020. This three-page document from TRACIE (Technical Resources, Assistance Center, and Information Exchange) is intended to provide information about crisis standards of care in a resource-constrained setting, such as the COVID-19 pandemic, to state, local, tribal, and territorial policymakers; healthcare systems leadership; and other decision-makers. (PDF)
04/10/2020 12:00 AM EDT

Source: National Highway Traffic Safety Administration, Office of Emergency Medical Services (EMS). Published: 4/10/2020. This two-page document provides steps that EMS clinicians and their medical directors can take to help patients and their families manage the distress of the COVID-19 pandemic more effectively. It was developed by the Healthcare Resilience Task Force Behavioral Health Work group and adapted by the Prehospital [911 and Emergency Medical Services (EMS)] Team. (PDF)
04/10/2020 12:00 AM EDT

Source: National Highway Traffic Safety Administration, Office of Emergency Medical Services (EMS). Published: 4/10/2020. This three-page document contains general concepts to prepare and take action, such as those listed, to help EMS/911 agencies protect their workers’ psychological health and well-being during the COVID-19 pandemic. It was developed by the Healthcare Resilience Task Force Behavioral Health Work group and adapted by the Prehospital [911 and Emergency Medical Services (EMS)] Team. (PDF)
04/06/2020 12:00 AM EDT

Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 4/6/2020. This web page provides COVID-19 guidance for alternate care sites, with information about Key Concepts, Physical Infrastructure, Services, and Patient Care Considerations. It provides critical infection prevention and control (IPC) considerations and is intended to supplement existing plans (created by jurisdictions as part of pandemic planning). (Text)
04/03/2020 12:00 AM EDT

Source: U.S. Food and Drug Administration (FDA). Published: 4/3/2020. This two-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Lungpacer Diaphragm Pacing Therapy System during the COVID-19 pandemic, which received an Emergency Use Authorization from the Food and Drug Administration on April 3, 2020. It is for use with patients with COVID-19 and other illnesses or conditions that require mechanical ventilation, who are not spontaneously breathing, and are expected to require prolonged ventilation. (PDF)
04/01/2020 12:00 AM EDT

Source: World Health Organization (WHO). Published: 4/2020. This two-module course aims to show the type of personal protective equipment (PPE) needed to correctly protect oneself during the COVID-19 pandemic. Module 1 is: How-to-guide for putting on and removing PPE according to droplet/contact precautions for COVID-19. Module 2 is: How-to-guide for putting on and removing PPE according to airborne/contact precautions for COVID-19 aerosol generating procedures. (Video or Multimedia)
04/01/2020 12:00 AM EDT

Source: National Institutes of Health (NIH). Published: 4/2020. The National Institutes of Health (NIH) Environmental influences on Child Health Outcomes (ECHO) COVID-19 Task Force led the development of the ECHO COVID-19 questionnaires. The Task Force, co-chaired by ECHO investigators Tracy Bastain, PhD, and Carrie Breton, PhD, of the Keck School of Medicine at the University of Southern California, and comprised of 21 additional cohort investigators, as well as representatives from the ECHO NIH Program Office, Coordinating Center (CC), Data Analysis Center (DAC), and Person-Reported Outcome (PRO) Core, developed questionnaires for pregnant women and caregivers, children ages 0 to 12 years old (via parent report), and adolescents ages 13 years and older (via self-report). The purpose of these questionnaires is to assess the impact of being infected with and living during the time of the COVID-19 outbreak. Questionnaire content includes original items developed by the Task Force, as well as modified items from existing surveys and source materials listed in the access notes. (Text)
04/01/2020 12:00 AM EDT

Source: AcademyHealth. Published: 4/2020. This 16-page report focuses on the information needs of the healthcare and community organizations engaged in the COVID-19 response. It outlines rapid-cycle evaluation priorities in the following six categories: Patient and community experience, engagement, and outcomes; Care delivery, management, decision-making, and operations; Workforce needs, training, and policies; Technology, data, and telehealth; Policies, including payment policy; and Collaboration and coordination. (PDF)
03/30/2020 12:00 AM EDT

Source: Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services] (HHS ASPR). Published: 3/30/2020. This 136-page toolkit was developed to help state, local, tribal, and territorial (SLTT) entities to address potential shortages in medical facilities during the 2020 COVID-19 pandemic. It is intended to provide technical assistance to SLTT entities in establishing and operationalizing alternate care sites (ACS). (PDF)
03/27/2020 12:00 AM EDT

Source: European Emergency Number Association (EENA). Published: 3/27/2020. This one-hour, 25-minute webinar discusses newly gathered information on the increase in number of emergency and the strategies followed by different countries during the COVID-pandemic, and how how different public organizations are relying on multi-channel public warning strategies to communicate with the public. (Video or Multimedia)
03/19/2020 12:00 AM EDT

Source: International Corrections and Prisons Association (ICPA). Published: 3/19/2020. This one-hour, seven-minute webinar covers understanding the basics of COVID-19 in a rapidly changing environment, establishing an operational framework to guide the response, keeping COVID-19 out of the prison environment, and responding to potential and actual cases of COVID-19 in the inmate population. (Video or Multimedia)

No hay comentarios: